Mineralys Therapeutics, Inc.
MLYSNasdaqCIK 1933414HealthcareFiscal year ends Dec 31
Reports and events: 76 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:08 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001933414-26-000136 |
| 2026-10-1916:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001933414-26-000125 |
| 2026-08-1117:18 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001933414-26-000114 |
| 2026-08-1116:08 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001933414-26-000112 |
| 2026-06-0316:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-040225 |
| 2026-06-0306:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001628280-26-040024 |
| 2026-05-2216:50 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001933414-26-000090 |
| 2026-05-0617:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001933414-26-000084 |
| 2026-05-0616:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-26-000082 |
| 2026-04-0808:47 ET | DEF 14A | Proxy statementPeriod 2026-05-21 | 0001933414-26-000069 |
| 2026-03-1217:19 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001933414-26-000056 |
| 2026-03-1216:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-26-000054 |
| 2026-03-0916:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-26-000048 |
| 2026-01-0608:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-26-000002 |
| 2025-11-1017:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001933414-25-000142 |
| 2025-11-1016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-25-000139 |
| 2025-09-0820:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-023916 |
| 2025-09-0818:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-023895 |
| 2025-09-0316:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-25-000120 |
| 2025-09-0217:00 ET | 8-K | 8.01 Other events | 0001933414-25-000107 |
| 2025-08-1217:20 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001933414-25-000090 |
| 2025-08-1216:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-25-000088 |
| 2025-06-1707:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-25-000070 |
| 2025-05-2216:14 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001933414-25-000064 |
| 2025-05-1217:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001933414-25-000058 |
| 2025-05-1216:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-25-000057 |
| 2025-04-0908:16 ET | DEF 14A | Proxy statementPeriod 2025-05-22 | 0001933414-25-000036 |
| 2025-03-3108:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-25-000026 |
| 2025-03-1721:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-008276 |
| 2025-03-1719:58 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-008259 |
| 2025-03-1216:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-012335 |
| 2025-03-1007:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-011459 |
| 2025-02-1209:22 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001933414-25-000009 |
| 2025-02-1207:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-25-000008 |
| 2025-02-0408:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-25-000006 |
| 2025-01-0808:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-25-000002 |
| 2024-11-1208:36 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001933414-24-000057 |
| 2024-11-1208:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-24-000056 |
| 2024-10-3008:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-24-000050 |
| 2024-09-2508:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-24-000044 |
| 2024-08-1316:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001933414-24-000039 |
| 2024-08-1316:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-24-000038 |
| 2024-06-1408:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001933414-24-000028 |
| 2024-06-1016:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-24-000025 |
| 2024-05-3116:06 ET | 8-K | 9.01 Financial statements and exhibits | 0001933414-24-000024 |
| 2024-05-2216:38 ET | 8-K | 5.07 Shareholder vote results | 0001933414-24-000017 |
| 2024-05-0907:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001933414-24-000016 |
| 2024-05-0907:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-24-000015 |
| 2024-04-0907:15 ET | DEF 14A | Proxy statementPeriod 2024-04-09 | 0001933414-24-000009 |
| 2024-04-0408:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001933414-24-000008 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:10 ET. Listed shows no prices and gives no investment advice.